Dublin, March 23, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/w8233k/global_3d) has announced the addition of the "Global 3D Bioprinting Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
The Global 3D Bioprinting Market is poised to grow at a CAGR of around 16.7% over the next decade to reach approximately $8.9 billion by 2025.
This industry report analyzes the global markets for 3D Bioprinting across all the given segments on global as well as regional levels presented in the research scope. It presents historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report provides comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.
The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Tissue Engineering and Dental Implants Set to Boost 3D Bioprinting
3.1.2 Recent Techlological Developments of 3D bioprinting
3.1.3 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
4 3D bioprinting Market, By Technology
4.1 Laser assisted
4.2 Syringe Based
4.3 Magnetic Levitation
4.4 Valve-based
4.5 Inkjet Based
5 3D bioprinting Market, By Application
5.1 Consumer/personal product testing
5.2 Food And Animal Product
5.3 Biosensors
5.4 Dental
5.5 Bioinks
5.6 Medical
6 3D bioprinting Market, By Geography
7 Leading Companies
- 3D Biotek
- 3D Systems
- Advanced Biomatrix
- Autodesk
- Avita Medical
- BD Biosciences
- Bespoke Innovations
- Bio3D Technologies
- CMC Microsystems
- Cyfuse Biomedical
- DTM
- Digilab
- EnvisionTEC
- TeVido BioDevices
- United Therapeutics
For more information visit http://www.researchandmarkets.com/research/w8233k/global_3d
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: 3D Printing


Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 



